Litigation Details for Aptalis Pharma US, Inc. v. Delcor Asset Corporation (D. Del. 2015)
✉ Email this page to a colleague
Aptalis Pharma US, Inc. v. Delcor Asset Corporation (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-12-27 |
| Court | District Court, D. Delaware | Date Terminated | 2016-04-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 8,217,083; 8,436,051 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Aptalis Pharma US, Inc. v. Delcor Asset Corporation
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Aptalis Pharma US, Inc. v. Delcor Asset Corporation (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-12-26 | 1 | expiration of U.S. Patent No. 7,541,384, U.S. Patent No. 8,217,083, and U.S. Patent No. 8,436,051. …Court. Count III: Infringement of U.S. Patent No. 8,217,083 38. Aptalis repeats and incorporates…Declaratory Judgment of Infringement of U.S. Patent No. 8,217,083 49. Aptalis repeats and incorporates…PageID #: 4 10. U.S. Patent No. 7,541,384 (“the ‘384 patent”) (attached as Exhibit A), titled…the U.S. Patent and Trademark Office (“USPTO”) on June 2, 2009. 11. U.S. Patent No. 8,217,083 | External link to document | |
| 2015-12-26 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,541,384; 8,217,083; 8,436,051. (…2015 19 April 2016 1:15-cv-01210 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-04-19 | 7 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,541,384; 8,217,083; 8,436,051. (…2015 19 April 2016 1:15-cv-01210 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
